Author | Jeffrey M. Clarke, MD | OncLive

Author | Jeffrey M. Clarke, MD

Articles

Dr. Clarke on Available EGFR TKIs in Frontline Treatment of EGFR+ NSCLC

July 04, 2019

Video

Jeffrey M. Clarke, MD, assistant professor of medicine, Duke Cancer Institute, discusses the available EGFR TKIs in the frontline setting for the treatment of patients with EGFR-positive non–small cell lung cancer (NSCLC).

Dr. Clarke on Combination Approaches Beyond Progression on Osimertinib in Lung Cancer

June 12, 2019

Video

Jeffrey M. Clarke, MD, assistant professor of medicine, Duke Cancer Institute, discusses combination approaches beyond progression on osimertinib (Tagrisso) in EGFR-mutant non–small cell lung cancer (NSCLC).

Dr. Clarke Compares TKIs in EGFR+ NSCLC

May 29, 2019

Video

Jeffrey M. Clarke, MD, assistant professor of medicine, Duke Cancer Institute, compares EGFR TKIs in EGFR-positive non–small cell lung cancer.

Dr. Clarke on the State of Biomarkers in NSCLC

March 13, 2018

Video

Jeffrey M. Clarke, MD, assistant professor of medicine, Duke Cancer Institute, discusses the evolution of biomarkers in directing treatment for patients with non–small cell lung cancer (NSCLC).

x